And just to reinforce the point:
US03-008 is Cohort 3 and is intravenous without pembro. At the Oct data cut-off, 120 days for this patient and achieved stable disease. Tumor reduction still evident in the Dec cut. so there's no progression here. Absolute bullsh1t to suggest otherwise.
"typically", "highly likely", "likely", "could mean" - all very speculative.
the only worthy statement in the whole piece:
"the nature of research is exploratory and ongoing, so the addition of cohorts and more patient data may prove to be in favor of or work against the clinical efficacy of CF33 in patients."
- Forums
- ASX - By Stock
- Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
And just to reinforce the point:US03-008 is Cohort 3 and is...
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M |
Open | High | Low | Value | Volume |
5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 3441484 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 574188 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 2626814 | 0.054 |
21 | 3124322 | 0.053 |
28 | 4941821 | 0.052 |
31 | 3703294 | 0.051 |
70 | 6394327 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 401800 | 3 |
0.056 | 100000 | 1 |
0.057 | 444535 | 7 |
0.058 | 400000 | 2 |
0.059 | 350000 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |